Abstract
Muscarinic receptors comprise five cloned subtypes, encoded by five distinct genes, which correspond to pharmacologically defined receptors (M1–M5). They belong to the family of G-protein-coupled receptors and couple differentially to the G-proteins. Preferentially, the inhibitory muscarinic M2 and M4 receptors couple to Gi/o, whereas the excitatory muscarinic M1, M3, and M5 receptors preferentially couple to Gq/11. In general, muscarinic M1, M3, and M5 receptors increase intracellular calcium by mobilizing phosphoinositides that generate inositol 1,4,5-trisphosphate (InsP3) and 1,2-diacylglycerol (DAG), whereas M2 and M4 receptors are negatively coupled to adenylyl cyclase. Muscarinic receptors are distributed to all parts of the lower urinary tract. The clinical use of antimuscarinic drugs in the treatment of detrusor overactivity and the overactive bladder syndrome has focused interest on the muscarinic receptors not only of the detrusor, but also of other components of the bladder wall, and these have been widely studied. However, the muscarinic receptors in the urethra, prostate, and ureter, and the effects they mediate in the normal state and in different urinary tract pathologies, have so far not been well characterized. In this review, the expression of and the functional effects mediated by muscarinic receptors in the bladder, urethra, prostate, and ureters, under normal conditions and in different pathologies, are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrams P, Andersson KE (2007) Muscarinic receptor antagonists for overactive bladder. BJU Int 100(5):987–1006
Alberts P (1995) Classification of the presynaptic muscarinic receptor subtype that regulates 3H-acetylcholine secretion in the guinea pig urinary bladder in vitro. J Pharmacol Exp Ther 274(1):458–468
An JY, Yun HS, Lee YP, Yang SJ, Shim JO, Jeong JH, Shin CY, Kim JH, Kim DS, Sohn UD (2002) The intracellular pathway of the acetylcholine-induced contraction in cat detrusor muscle cells. Br J Pharmacol 137(7):1001–1010
Andersson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45(3):253–308
Andersson KE (2004a) Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3(1):46–53
Andersson K-E (2004b) Detrusor contraction – focus on muscarinic receptors. Scand J Urol Nephrol Suppl 215:54–57
Andersson KE, Wein AJ (2004) Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 56(4):581–631
Andersson KE, Persson CG, Alm P, Kullander S, Ulmsten U (1978) Effects of acetylcholine, noradrenaline, and prostaglandins on the isolated, perfused human fetal urethra. Acta Physiol Scand 104(4):394–401
Andersson KE, Holmquist F, Fovaeus M, Hedlund H, Sundler R (1991) Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human isolated urinary bladder. J Urol 146(4):1156–1159
Andersson K-E, Chapple CR, Cardozo L et al (2009) Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence, 4th international consultation on incontinence. Plymouth. Plymbridge Distributors Ltd, Plymouth, UK, pp 631–699
Anisuzzaman AS, Morishima S, Suzuki F, Tanaka T, Yoshiki H, Sathi ZS, Akino H, Yokoyama O, Muramatsu I (2008) Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay. J Pharmacol Sci 106(2):271–279
Arrighi S, Bosi G, Cremonesi F, Domeneghini C (2008) Immunohistochemical study of the pre- and postnatal innervation of the dog lower urinary tract: morphological aspects at the basis of the consolidation of the micturition reflex. Vet Res Commun 32(4):291–304
Arvidsson U, Riedl M, Elde R, Meister B (1997) Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 378(4):454–467
Barendrecht MM, Oelke M, Laguna MP, Michel MC (2007) Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int 99(4):749–752
Bayliss M, Wu C, Newgreen D, Mundy AR, Fry CH (1999) A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 162(5):1833–1839
Blanco M, Robinson MJ (2004) Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue. Ann Diagn Pathol 8(6):333–336
Bonev AD, Nelson MT (1993) Muscarinic inhibition of ATP-sensitive K+ channels by protein kinase C in urinary bladder smooth muscle. Am J Physiol 265(6 Pt 1):C1623–C1628
Braverman AS, Ruggieri MR Sr (2003) Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2. Am J Physiol Regul Integr Comp Physiol 285(3):R701–R708
Braverman AS, Luthin GR, Ruggieri MR (1998) M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder. Am J Physiol 275:R1654–R1660
Braverman A, Legos J, Young W, Luthin G, Ruggieri M (1999) M2 receptors in genito-urinary smooth muscle pathology. Life Sci 64:429–436
Braverman AS, Tallarida RJ, Ruggieri MR Sr (2002) Interaction between muscarinic receptor subtype signal transduction pathways mediating bladder contraction. Am J Physiol Regul Integr Comp Physiol 283(3):R663–R668
Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, Lips KS (2007) Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 80(24–25):2303–2307
Caine M, Raz S, Zeigler M (1975) Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 47(2):193–202
Caulfield MP, Birdsall NJM (1998) International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279–290
Chapple CR, Crowe R, Gilpin SA, Gosling J, Burnstock G (1991) The innervation of the human prostate gland – the changes associated with benign enlargement. J Urol 146(6):1637–1644
Chapple C, Khullar V, Gabriel Z, Dooley JA (2005) The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48(1):5–26
Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D (2008) The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 54(3):543–562
Charlton RG, Morley AR, Chambers P, Gillespie JI (1999) Focal changes in nerve, muscle and connective tissue in normal and unstable human bladder. BJU Int 84(9):953–960
Cheng JT, Yu BC, Tong YC (2007) Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats. Neurosci Lett 423(1):1–5
Chess-Williams R (2002) Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 22(3):133–145
D’Agostino G, Barbieri A, Chiossa E, Tonini M (1997) M4 muscarinic autoreceptor-mediated inhibition of -3H-acetylcholine release in the rat isolated urinary bladder. J Pharmacol Exp Ther 283(2):750–756
D’Agostino G, Bolognesi ML, Lucchelli A, Vicini D, Balestra B, Spelta V, Melchiorre C, Tonini M (2000) Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br J Pharmacol 129(3):493–500
Dass N, McMurray G, Greenland JE, Brading AF (2001) Morphological aspects of the female pig bladder neck and urethra: quantitative analysis using computer assisted 3-dimensional reconstructions. J Urol 165(4):1294–1299
De Laet K, De Wachter S, Wyndaele JJ (2006) Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics. Neurourol Urodyn 25(2):156–161
De Wachter S, Wyndaele JJ (2001) Does bladder tone influence sensation of filling and electro-sensation in the bladder? A blind controlled study in young healthy volunteers using bethanechol. J Urol 165(3):802–804
De Wachter S, Van Meel TD, Wyndaele JJ (2003) Study of the afferent nervous system and its evaluation in women with impaired detrusor contractility treated with bethanechol. Urology 62(1):54–58
Dixon JS, Jen PY, Gosling JA (2000) The distribution of vesicular acetylcholine transporter in the human male genitourinary organs and its co-localization with neuropeptide Y and nitric oxide synthase. Neurourol Urodyn 19(2):185–194
Eglen RM, Hegde SS, Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48:531–565
Ehlert FJ, Griffin MT, Abe DM, Vo TH, Taketo MM, Manabe T, Matsui M (2005) The M 2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder. J Pharmacol Exp Ther 313:368–378
Ek A, Alm P, Andersson KE, Persson CG (1977) Adrenergic and cholinergic nerves of the human urethra and urinary bladder. A histochemical study. Acta Physiol Scand 3:345–352
Ek A, Andersson KE, Ulmsten U (1978) The effects of norephedrine and bethanechol on the human urethral closure pressure profile. Scand J Urol Nephrol 12(2):97–104
el-Salmy S, Downie JW, Awad SA (1985) Bladder and urethral function and supersensitivity to subcutaneously administered bethanechol in cats with chronic cauda equina lesions. J Urol 134(5):1011–1018
Finkbeiner AE (1985) Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review. J Urol 134(3):443–449
Finney SM, Andersson KE, Gillespie JI, Stewart LH (2006) Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 98(3):503–507
Frazier EP, Braverman AS, Peters SLM, Michel MC, Ruggieri MR Sr (2007) Does phospholipase C mediate muscarinic receptor-induced rat urinary bladder contraction? J Pharmacol Exp Ther 322:998–1002
German K, Bedwani J, Davies J, Brading AF, Stephenson TP (1995) Physiological and morphometric studies into the pathophysiology of detrusor hyperreflexia in neuropathic patients. J Urol 153:1678–1683
Giglio D, Tobin G (2009) Muscarinic receptor subtypes in the lower urinary tract. Pharmacology 83(5):259–269
Giglio D, Ryberg AT, To K, Delbro DS, Tobin G (2005) Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats. Auton Neurosci 122(1–2):9–20
Goepel M, Gronewald A, Krege S, Michel MC (1998) Muscarinic receptor subtypes in porcine detrusor: comparison with humans and regulation by bladder augmentation. Urol Res 26:149–154
Gosling JA, Gilpin SA, Dixon JS, Gilpin CJ (1986) Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. J Urol 136:501–504
Grol S, Essers PB, van Koeveringe GA, Martinez-Martinez P, de Vente J, Gillespie JI (2009) M(3) muscarinic receptor expression on suburothelial interstitial cells. BJU Int 104(3):398–405
Guay DR (2003) Clinical pharmacokinetics of drugs used to treat urge incontinence. Clin Pharmacokinet 42(14):1243–1285
Gudermann T, Kalkbrenner F, Schultz G (1996) Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol 36:429–459
Gup DI, Baumann M, Lepor H, Shapiro E (1989a) Muscarinic cholinergic receptors in normal pediatric and myelodysplastic bladders. J Urol 142(2 Pt 2):595–599, discussion 603–605
Gup DI, Shapiro E, Baumann M, Lepor H (1989b) Contractile properties of human prostate adenomas and the development of infravesical obstruction. Prostate 15(2):105–114
Gup DI, Shapiro E, Baumann M, Lepor H (1990) Autonomic receptors in human prostate adenomas. J Urol 143(1):179–185
Harrison SCV, Hunnam GR, Farman P, Doyle PT (1987) Bladder instability and denervation in patients with bladder outflow obstruction. Br J Urol 60:519–522
Harriss DR, Marsh KA, Birmingham AT, Hill SJ (1995) Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol 154(3):1241–1245
Hashitani H, Suzuki H (1996) Altered electrical properties of bladder smooth muscle in streptozotocin-induced diabetic rats. Br J Urol 77(6):798–804
Hawthorn MH, Chapple CR, Cock M, Chess-Williams R (2000) Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 129(3):416–419
Hedlund H, Andersson KE (1988) Effects of prazosin and carbachol in patients with benign prostatic obstruction. Scand J Urol Nephrol 22(1):19–22
Hedlund H, Andersson KE, Larsson B (1985) α-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 134(6):1291–1298
Hedlund P, Ekström P, Larsson B, Alm P, Andersson KE (1997) Heme oxygenase and NO-synthase in the human prostate – relation to adrenergic, cholinergic and peptide-containing nerves. J Auton Nerv Syst 63(3):115–126
Hegde SS, Eglen RM (1999) Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci 64(6–7):419–428
Hegde SS, Choppin A, Bonhaus D et al (1997) Functional role of M-2 and M-3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol 120:1409–1418
Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Br Med J 326:841–844
Hernández M, Símonsen U, Prieto D, Rivera L, García P, Ordaz E, García-Sacristán A (1993) Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter. Br J Pharmacol 110(4):1413–1420
Hernández M, García-Sacristán A, Orensanz LM (1995) Muscarinic binding sites of the pig intravesical ureter. J Auton Pharmacol 15(5):351–359
Igawa Y, Zhang X, Nishizawa O, Umeda M, Iwata A, Taketo MM, Manabe T, Matsui M, Andersson KE (2004) Cystometric findings in mice lacking muscarinic M 2 or M 3 receptors. J Urol 172:2460–2464
Iijima K, De Wachter S, Wyndaele JJ (2007) Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve. Eur Urol 52(3):842–847
Ikeda Y, Birder L, Buffington C, Roppolo J, Kanai A (2009) Mucosal muscarinic receptors enhance bladder activity in cats with feline interstitial cystitis. J Urol 181(3):1415–1422
Inadome A, Yoshida M, Takahashi W, Yono M, Seshita H, Miyamoto Y, Kawano T, Ueda S (1998) Prejunctional muscarinic receptors modulating acetylcholine release in rabbit detrusor smooth muscles. Urol Int 61(3):135–141
James S, Chapple CR, Phillips MI, Greengrass PM, Davey MJ, Turner-Warwick RT, Milroy EJ, Burnstock G (1989) Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate. J Urol 142(2 Pt 1):438–444
Jezior JR, Brady JD, Rosenstein DI, McCammon KA, Miner AS, Ratz PH (2001) Dependency of detrusor contractions on calcium sensitization and calcium entry through LOE-908-sensitive channels. Br J Pharmacol 134(1):78–87
Johns A (1983) Alpha- and beta-adrenergic and muscarinic cholinergic binding sites in the bladder and urethra of the rabbit. Can J Physiol Pharmacol 61(1):61–66
Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, Kummer W (2009) Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 379(4):389–395
Kaplan SA, Te AE, Blaivas JG (1995) Urodynamic findings in patients with diabetic cystopathy. J Urol 153:342–344
Kester RR, Mooppan UM, Gousse AE, Alver JE, Gintautas J, Gulmi FA, Abadir AR, Kim H (2003) Pharmacological characterization of isolated human prostate. J Urol 170(3):1032–1038
Kinder RB, Mundy AR (1987) Pathophysiology of idiopathic detrusor instability and detrusor hyper-reflexia. An in vitro study of human detrusor muscle. Br J Urol 60(6):509–515
Koraitim MM (2008) The male urethral sphincter complex revisited: an anatomical concept and its physiological correlate. J Urol 179(5):1683–1689
Kotlikoff MI, Dhulipala P, Wang YX (1999) M2 signaling in smooth muscle cells. Life Sci 64(6–7):437–442
Krichevsky VP, Pagala MK, Vaydovsky I, Damer V, Wise GJ (1999) Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction. J Urol 161(5):1644–1650
Latifpour J, Gousse A, Kondo S, Morita T, Weiss RM (1989) Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. J Pharmacol Exp Ther 248:81–88
Lepor H, Kuhar MJ (1984) Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue. J Urol 132(2):397–402
Lincoln J, Burnstock G (1993) Autonomic innervation of the urinary bladder and urethra. In: Maggi CA (ed) The autonomic nervous system, vol 6, Nervous control of the urogenital system, Chapter 2. Harwood Academic, London, pp 33–68
Long S, Nergårdh A (1978) Autonomic receptor functions of the human ureter: an in vitro study. Scand J Urol Nephrol 12(1):23–26
Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E (2005) Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol 144(8):1089–1099
Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E (2007) Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity. BJU Int 99(6):1433–1438
Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E (2009) Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther 328(3):893–899
Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T, Taketo MM (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22(24):10627–10632
Mattiasson A, Andersson KE, Sjögren C (1984) Adrenoceptors and cholinoceptors controlling noradrenaline release from adrenergic nerves in the urethra of rabbit and man. J Urol 131(6):1190–1195
Mattiasson A, Andersson KE, Andersson PO, Larsson B, Sjögren C, Uvelius B (1990) Nerve-mediated functions in the circular and longitudinal muscle layers of the proximal female rabbit urethra. J Urol 143(1):155–160
Michel MC, Hegde SS (2006) Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites? Naunyn Schmiedebergs Arch Pharmacol 374(2):79–85
Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379(4):385–388
Mills IW, Greenland JE, McMurray G, McCoy R, Ho KHT, Noble JG, Brading AF (2000) Studies of the pathophysiology of idiopathic detrusor instability: the physiological properties of the detrusor smooth muscle and its pattern of innervation. J Urol 163:646–651
Mimata H, Wheeler MA, Fukomoto Y, Takigawa H, Nishimoto T, Weiss RM, Latifpour J (1995) Enhancement of muscarinic receptor-coupled phosphatidyl inositol hydrolysis in diabetic bladder. Mol Cell Biochem 152:71–76
Mukerji G, Yiangou Y, Grogono J, Underwood J, Agarwal SK, Khullar V, Anand P (2006) Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 176(1):367–373
Mutoh S, Latifpour J, Saito M, Weiss RM (1997) Evidence for the presence of regional differences in the subtype specificity of muscarinic receptors in rabbit lower urinary tract. J Urol 157(2):717–721
Nagahama K, Tsujii T, Morita T, Azuma H, Oshima H (1998) Differences between proximal and distal portions of the male rabbit posterior urethra in the physiological role of muscarinic cholinergic receptors. Br J Pharmacol 124(6):1175–1180
Nakamura T, Kimura J, Yamaguchi O (2002) Muscarinic M2 receptors inhibit Ca2+-activated K+ channels in rat bladder smooth muscle. Int J Urol 9(12):689–696
Nemeth L, O’Briain DS, Puri P (2001) Demonstration of neuronal networks in the human upper urinary tract using confocal laser scanning microscopy. J Urol 166(1):255–258
Novara G, Galfano A, Secco S, D’Elia C, Cavalleri S, Ficarra V, Artibani W (2008) A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 54(4):740–763
Obara K, Arai K, Miyajima N, Hatano A, Tomita Y, Takahashi K (2000) Expression of m2 muscarinic acetylcholine receptor mRNA in primary culture of human prostate stromal cells. Urol Res 28(3):196–200
Pandita RK, Fujiwara M, Alm P, Andersson KE (2000) Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction. J Urol 164(4):1385–1389
Persson CG, Andersson KE (1976) Adrenoceptor and cholinoceptor mediated effects in the isolated urethra of cat and guinea-pig. Clin Exp Pharmacol Physiol 3(5):415–426
Persson K, Alm P, Johansson K, Larsson B, Andersson KE (1995) Co-existence of nitrergic, peptidergic and acetylcholine esterase-positive nerves in the pig lower urinary tract. J Auton Nerv Syst 52(2–3):225–236
Persson K, Johansson K, Alm P, Larsson B, Andersson KE (1997) Morphological and functional evidence against a sensory and sympathetic origin of nitric oxide synthase-containing nerves in the rat lower urinary tract. Neuroscience 77(1):271–281
Pradidarcheep W, Labruyere WT, Dabhoiwala NF, Lamers WH (2008) Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem 56:1099–1111
Pradidarcheep W, Stallen J, Labruyere WT, Dabhoiwala NF, Michel MC, Lamers WH (2009) Lack of specificity of commercially available antisera against muscarinic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 379:397–402
Prieto D, Simonsen U, Martín J, Hernández M, Rivera L, Lema L, García P, García-Sacristán A (1994) Histochemical and functional evidence for a cholinergic innervation of the equine ureter. J Auton Nerv Syst 47(3):159–170
Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK, Shah GV (1997) Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 30(3):160–166
Restorick JM, Mundy AR (1989) The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyper-reflexic human detrusor. Br J Urol 63(1):32–35
Riedl CR, Stephen RL, Daha LK, Knoll M, Plas E, Pflüger H (2000) Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol 164(6):2108–2111
Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350(10):1013–1022
Rolle U, Chertin B, Nemeth L, Puri P (2002) Demonstration of nitrergic and cholinergic innervation in whole-mount preparations of rabbit, pig, and human upper urinary tract. Pediatr Surg Int 18(5–6):315–318
Rolle U, Brylla E, Tillig B, Chertin B, Cascio S, Puri P (2008) Demonstration of intrinsic innervation of the guinea pig upper urinary tract using whole-mount preparation. Neurourol Urodyn 27(4):341–347
Roosen A, Wu C, Sui GP, Fry CH (2008) Synergistic effects in neuromuscular activation and calcium-sensitization in the bladder trigone. BJU Int 101(5):610–614
Ruggieri MR Sr, Braverman AS (2006) Regulation of bladder muscarinic receptor subtypes by experimental pathologies. Auton Autacoid Pharmacol 26(3):311–325
Ruggieri MR, Colton MD, Wang P, Wang J, Smyth RJ, Pontari MA, Luthin GR (1995) Human prostate muscarinic receptor subtypes. J Pharmacol Exp Ther 274(2):976–982
Sakamoto K, Suri D, Rajasekaran M (2006) Characterization of muscarinic receptor subtypes in human ureter. J Endourol 20(11):939–942
Schneider T, Fetscher C, Krege S, Michel MC (2004a) Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther 309(3):1148–1153
Schneider T, Hein P, Michel MC (2004b) Signal transduction underlying carbachol-induced contraction of rat urinary bladder. I. Phospholipases and Ca2+ sources. J Pharmacol Exp Ther 308(1):47–53
Schulman CC (1975) Ultrastructural evidence for adrenergic and cholinergic innervation of the human ureter. J Urol 113(6):765–771
Sibley GN (1984) A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol 354:431–443
Sibley GNA (1987) The physiological response of the detrusor muscle to experimental bladder outflow obstruction in the pig. Br J Urol 60:332–336
Sigala S, Mirabella G, Peroni A, Pezzotti G, Simeone C, Spano P, Cunico SC (2002) Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. Urology 60(4):719–725
Sjögren C, Andersson KE, Husted S, Mattiasson A, Moller-Madsen B (1982) Atropine resistance of transmurally stimulated isolated human bladder muscle. J Urol 128(6):1368–1371
Somogyi GT, de Groat WC (1992) Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder. J Auton Nerv Syst 37(2):89–97
Somogyi GT, de Groat WC (1999) Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder. Life Sci 64(6–7):411–418
Somogyi GT, Zernova GV, Yoshiyama M, Rocha JN, Smith CP, de Groat WC (2003) Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury. Neurochem Int 43(1):73–77
Speakman MJ, Brading AF, Gilpin CJ, DixonJS GSA, Gosling J (1987) Bladder outflow obstruction – a cause of denervation supersensitivity. J Urol 138:1461–1466
Speakman MJ, Walmsley D, Brading AF (1988) An in vitro pharmacological study of the human trigone – a site of non-adrenergic, non-cholinergic neurotransmission. Br J Urol 61(4):304–309
Stevens LA, Sellers DJ, McKay NG, Chapple CR, Chess-Williams R (2006) Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder. Auton Autacoid Pharmacol 26(3):303–309
Stevens LA, Chapple CR, Chess-Williams R (2007) Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction. Eur Urol 52(2):531–538
Tagliani M, Candura SM, Di Nucci A, Franceschetti GP, D’Agostino G, Ricotti P, Fiori E, Tonini M (1997) A re-appraisal of the nature of the atropine-resistant contraction to electrical field stimulation in the human isolated detrusor muscle. Naunyn Schmiedebergs Arch Pharmacol 356(6):750–755
Taki N, Taniguchi T, Okada K, Moriyama N, Muramatsu I (1999) Evidence for predominant mediation of alpha1-adrenoceptor in the tonus of entire urethra of women. J Urol 162(5):1829–1832
Taylor JA III, Kuchel GA (2006) Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc 54(12):1920–1932
Tobin G, Sjögren C (1995) In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [ 3 H]acetylcholine in the rabbit urinary bladder. Eur J Pharmacol 281:1–8
Tomiyama Y, Wanajo I, Yamazaki Y, Murakami M, Kojima M, Shibata N (2003) Functional muscarinic cholinoceptors in the isolated canine ureter. Naunyn Schmiedebergs Arch Pharmacol 367(4):348–352
Tomiyama Y, Wanajo I, Yamazaki Y, Kojima M, Shibata N (2004) Effects of cholinergic drugs on ureteral function in anesthetized dogs. J Urol 172(4 Pt 1):1520–1523
Tong YC, Cheng JT, Hsu CT (2006) Alterations of M(2)-muscarinic receptor protein and mRNA expression in the urothelium and muscle layer of the streptozotocin-induced diabetic rat urinary bladder. Neurosci Lett 406(3):216–221
Turner WH, Brading AF (1997) Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment. Pharmacol Ther 75(2):77–110
Twiddy DA, Downie JW, Awad SA (1980) Response of the bladder to bethanechol after acute spinal cord transection in cats. J Pharmacol Exp Ther 215(2):500–506
Tyagi S, Tyagi P, Van-le S, Yoshimura N, Chancellor MB, de Miguel F (2006) Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol 176(4 Pt 1):1673–1678
Ulmsten U, Andersson KE (1977) The effects of emeprone on intravesical and intra-urethral pressure in women with urgency incontinence. Scand J Urol Nephrol 11(2):103–109
van Koppen CJ, Kaiser B (2003) Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 98(2):197–220
Wang P, Luthin GR, Ruggieri MR (1995) Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther 273:959–966
Werner ME, Knorn AM, Meredith AL, Aldrich RW, Nelson MT (2007) Frequency encoding of cholinergic- and purinergic-mediated signaling to mouse urinary bladder smooth muscle: modulation by BK channels. Am J Physiol Regul Integr Comp Physiol 292(1):R616–R624
Wibberley A, Chen Z, Hu E, Hieble JP, Westfall TD (2003) Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. Br J Pharmacol 138(5):757–766
Witte LP, Chapple CR, de la Rosette JJ, Michel MC (2008) Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol 54(2):326–334
Wu G, Bogatkevich GS, Mukhin YV, Benovic JL, Hildebrandt JD, Lanier SM (2000) Identification of Gβγ binding sites in the third intracellular loop of the M 3 -muscarinic receptor and their role in receptor regulation. J Biol Chem 275:9026–9034
Yamaguchi O, Shishido K, Tamura K et al (1996) Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle. J Urol 156:1208–1213
Yamamoto M, Unno T, Matsuyama H, Kohda M, Masuda N, Nishimura M, Ishii T, Komori S (2008) Two types of cation channel activated by stimulation of muscarinic receptors in guinea-pig urinary bladder smooth muscle. J Pharmacol Sci 108(3):248–257
Yamanishi T, Chapple CR, Yasuda K, Chess-Williams R (2000) The role of M2 -muscarinic receptors in mediating contraction of the pig urinary bladder in vitro. Br J Pharmacol 131:1482–1488
Yokoyama O, Nagano K, Kawaguchi K, Hisazumi H (1991) The response of the detrusor muscle to acetylcholine in patients with infravesical obstruction. Urol Res 19:117–121
Yoshida M, Miyamae K, Iwashita H, Otani M, Inadome A (2004) Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63(3 Suppl 1):17–23
Yoshida M, Inadome A, Maeda Y, Satoji Y, Masunaga K, Sugiyama Y, Murakami S (2006) Non-neuronal cholinergic system in human bladder urothelium. Urology 67(2):425–430
Yoshida M, Masunaga K, Satoji Y, Maeda Y, Nagata T, Inadome A (2008) Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance. J Pharmacol Sci 106(2):193–198
Yoshimura N, Kaiho Y, Miyazato M, Yunoki T, Tai C, Chancellor MB, Tyagi P (2008) Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol 377(4–6):437–448
Zhou H, Meyer A, Starke K, Gomeza J, Wess J, Trendelenburg AU (2002) Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 365(2):112–122
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Andersson, KE. (2011). Muscarinic Acetylcholine Receptors in the Urinary Tract. In: Andersson, KE., Michel, M. (eds) Urinary Tract. Handbook of Experimental Pharmacology, vol 2011. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16499-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-16499-6_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16498-9
Online ISBN: 978-3-642-16499-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)